Nephro Care India Limited — Others, 29-05-2025: Statement of deviation(s) or variation(s) under Reg. 32

Nephro Care India Limited has announced a board meeting where it reviewed the utilization of IPO proceeds for the half year ended March 31, 2025. The company confirmed no deviations or variations in the use of funds raised through its IPO, consistent with its planned capital deployment. This disciplined financial management, verified by statutory auditors, reinforces transparency and is reassuring for shareholders.